In ovarian cancer, the activation of NF-κB enhances the aggressiveness of tumor, facilitates the formation of an immune-evasive microenvironment, and recruits pro-tumorigenic immune cells, which in turn promote the survival and metastasis of cancer cells [53, 54]. This evidence concerns the gene NFKB1 and ovarian cancer.